{"id":3529,"date":"2016-07-13T08:33:16","date_gmt":"2016-07-13T12:33:16","guid":{"rendered":"https:\/\/medicarereport.org\/?p=3529"},"modified":"2016-07-13T08:33:16","modified_gmt":"2016-07-13T12:33:16","slug":"republicans-embrace-the-right-to-try-to-get-experimental-medicines","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=3529","title":{"rendered":"Republicans embrace the \u2018Right to Try\u2019 to get experimental medicines"},"content":{"rendered":"<p>(By Ed Silverman for ST<em>A<\/em>T)<\/p>\n<p><span class=\"big-cap\">T<\/span>he \u201cRight to Try\u201d movement may be embedded in the Republican Party platform.<\/p>\n<p class=\"danger-zone\">Amid the run up to the <a href=\"https:\/\/www.statnews.com\/2016\/07\/12\/conventions-hospitals-cleveland-philadelphia\/\" target=\"_blank\">Republican National Convention<\/a> that begins in Cleveland next week, the party has adopted an amendment in its draft platform that endorses a controversial stance toward obtaining treatments for fatal illnesses. Known as Right to Try, the concept is designed to allow desperately sick people to gain access to experimental medicines. <a href=\"https:\/\/www.statnews.com\/pharmalot\/2016\/07\/12\/republicans-convention-experimental-medicines\/\" target=\"_blank\">Read article here&#8230;..<\/a><\/p>\n<pre><strong>Notice<\/strong>: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By Ed Silverman for STAT) The \u201cRight to Try\u201d movement may be embedded in the Republican Party platform. Amid the<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17,15],"tags":[],"class_list":["post-3529","post","type-post","status-publish","format-standard","hentry","category-emerging-health-issues","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/3529","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3529"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/3529\/revisions"}],"predecessor-version":[{"id":3530,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/3529\/revisions\/3530"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3529"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3529"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3529"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}